XML 278 R68.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Segment Information    
Summary of key metrics for evaluating performance of company

​

​

​

​

​

​

​

​

​

​

For the Three Months ended

​

​

September 30,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

​

$

3,361,858

​

$

1,248,189

General and administrative expenses

​

 

4,749,399

​

 

1,125,121

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

287,095

​

 

316,711

Total Operating Expenses

​

$

(8,398,352)

​

$

(2,690,021)

​

​

​

​

​

​

​

​

​

​

For the Nine Months ended

​

​

September 30,

​

  ​ ​ ​

2025

  ​ ​ ​

2024

Research and development costs

​

$

6,211,043

​

$

3,755,549

General and administrative expenses

​

 

11,569,376

​

 

3,546,510

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

665,832

​

 

1,015,118

Total Operating Expenses

​

$

(18,446,251)

​

$

(8,317,177)

​

​

​

​

​

​

​

​

​

​

For the year ended

​

​

December 31,

​

  ​ ​ ​

2024

  ​ ​ ​

2023

Research and development costs

​

$

5,176,932

​

$

7,152,913

General and administrative expenses

​

 

4,168,576

​

 

5,274,603

Other significant non-cash items:

​

 

  ​

​

 

  ​

Depreciation and amortization

​

 

1,256,391

​

 

1,829,997

Total Operating Expenses

​

 

10,601,899

​

 

14,257,513

Revenue

​

 

248,357

​

 

18,614

Total other items

​

 

(1,110,903)

​

 

74,792

Income tax (expense) benefit

​

 

(20,965)

​

 

356,437

Net loss

​

$

(11,485,410)

​

$

(13,807,670)